Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Tildrakizumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sun Pharma Announces US FDA Acceptance of sBLA for ILUMYA
    Sun Pharma Announces US FDA Acceptance of sBLA for ILUMYA

    16 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sun-pharma-announces-us-fda-acceptance-of-supplemental-biologics-license-sbla-application-for-ilumya-tildrakizumab-asmn-for-the-treatment-of-adults-with-active-psoriatic-arthritis-302714083.html

    PR NEWSWIRE
    16 Mar 2026
    Share Share
    Sun Pharma Presents Dermatology & Immunology Portfolio Data
    Sun Pharma Presents Dermatology & Immunology Portfolio Data

    27 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sun-pharma-showcases-data-across-its-dermatology--immunology-portfolio-at-2026-winter-clinical-miami-302699714.html

    PR NEWSWIRE
    27 Feb 2026
    Share Share
    DoP May Exempt 11 More Drugs from Global Tenders
    DoP May Exempt 11 More Drugs from Global Tenders

    13 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183515&sid=1

    PHARMABIZ
    13 Jan 2026
    Share Share
    Sun Pharma Launches Ilumya For Psoriasis Treatment In India
    Sun Pharma Launches Ilumya For Psoriasis Treatment In India

    01 Dec 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-launches-ilumya-psoriasis-treatment-in-india/articleshow/125696375.cms

    ECONOMICTIMES
    01 Dec 2025
    Share Share
    Almirall Advances Skin Science at EADV 2025 for Holistic Care
    Almirall Advances Skin Science at EADV 2025 for Holistic Care

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/eadv-2025-almirall-advances-skin-science-and-leads-innovation-for-holistic-patient-care-in-medical-dermatology

    PHARMAWEB
    17 Sep 2025
    Share Share
    Sun Pharma’s phase 3 clinical studies evaluating ILUMYA
    Sun Pharma’s phase 3 clinical studies evaluating ILUMYA

    21 Jul 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/sun-pharmas-phase-3-clinical-studies-evaluating-ilumya-in-active-psoriatic-arthritis-met-their-primary-endpoint/

    EXPRESSPHARMA
    21 Jul 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.